Literature DB >> 26668534

Co-existent breast and renal cancer.

Orhan Üreyen1, Emrah Dadalı1, Fırat Akdeniz2, Tamer Şahin3, Mehmet Tahsin Tekeli1, Nuket Eliyatkın3, Hakan Postacı3, Enver İlhan1.   

Abstract

The concomitant presence of breast cancer with one or more other types of cancer such as colon, vulva, lung, larynx, liver, uterus and kidneys has been presented in the literature. However, synchronous breast and renal cancer is very uncommon. Herein we present a woman with synchronous breast and renal cancer, and review the literature. A 77-year-old post-menopausal woman was admitted to our clinic complaining of left sided breast mass. On physical examination, there was a 3 cm palpable mass in the upper outer quadrant of the left breast along with a conglomerate of lymph nodes in the left axilla. Ultrasonography and mammography showed a 3 cm solid, hypoechoic mass in the upper outer quadrant and left axillary lymphadenopathy. The tru-cut biopsy of the lesion revealed invasive ductal carcinoma. The bone scintigraphy, thoracic and cranial computerized tomographies were normal. The abdominal computerized tomography identified a 3×3 cm solid renal mass with heterogeneous contrast enhancement in the posterior segment of the lower pole, which was suspicious for renal cell carcinoma. Breast conserving surgery and axillary lymph node dissection was performed, and the pathology specimen demonstrated invasive ductal carcinoma. The patient was discharged on postoperative day 5. Three weeks later partial nephrectomy was performed by urology department for the solid renal mass, and the pathology result showed clear cell-renal carcinoma with Fuhrman grade 3. The patient is being followed-up for renal carcinoma, and underwent radiotherapy for breast cancer. Hormonotherapy for breast cancer is still continuing.

Entities:  

Keywords:  Breast cancer; renal cell carcinoma; synchronous tumors

Year:  2015        PMID: 26668534      PMCID: PMC4674048          DOI: 10.5152/UCD.2015.2874

Source DB:  PubMed          Journal:  Ulus Cerrahi Derg        ISSN: 1300-0705


  7 in total

1.  Incidence and prognostic significance of second primary cancers in renal cell carcinoma.

Authors:  Subhankar Chakraborty; Stefano R Tarantolo; Surinder K Batra; Ralph J Hauke
Journal:  Am J Clin Oncol       Date:  2013-04       Impact factor: 2.339

2.  Synchronous primary malignancies in breast and kidney: a rare case report.

Authors:  U A Kurlekar; A S Rayate
Journal:  Indian J Surg       Date:  2014-01-11       Impact factor: 0.656

3.  Random synchronous malignancy in male breast: a case report.

Authors:  Manjit Sarma; Chaitanya Borde; Padma Subramanyam; Palaniswamy Shanmuga Sundaram
Journal:  J Breast Cancer       Date:  2013-12-31       Impact factor: 3.588

4.  Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese patients.

Authors:  Feng Jiao; Li-Juan Yao; Jin Zhou; Hai Hu; Li-Wei Wang
Journal:  Asian Pac J Cancer Prev       Date:  2014

5.  A novel combination of multiple primary carcinomas: urinary bladder transitional cell carcinoma, prostate adenocarcinoma and small cell lung carcinoma--report of a case and review of the literature.

Authors:  Anastassios V Koutsopoulos; Konstantina I Dambaki; George Datseris; Elpida Giannikaki; Marios Froudarakis; Efstathios Stathopoulos
Journal:  World J Surg Oncol       Date:  2005-07-26       Impact factor: 2.754

6.  Successful treatment of triple primary tumor.

Authors:  Sidika Kurul; Zuleyha Akgun; Esra Kaytan Saglam; Mert Basaran; Serap Yucel; Sitki Tuzlali
Journal:  Int J Surg Case Rep       Date:  2013-08-27

7.  Synchronous primary neoplasms of the bladder, skin and breast in a male patient: a case report.

Authors:  Antonio Luigi Pastore; Giovanni Palleschi; Domenico Autieri; Antonino Leto; Andrea Ripoli; Cristina Maggioni; Davide Moschese; Yazan Al Salhi; Natale Porta; Claudio Di Cristofano; Andrea Fuschi; Luigi Silvestri; Carlo Della Rocca; Silverio Tomao; Vincenzo Petrozza; Antonio Carbone
Journal:  World J Surg Oncol       Date:  2013-10-20       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.